Friday, August 10, 2018

Dose Optimization of H56:IC31 Vaccine for TB Endemic Populations: A Double-Blind, Placebo-Controlled, Dose-Selection Trial.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)